Rensselaer Polytechnic Institute

Iridium Names Jacqueline Yeaney to Board of Directors

Retrieved on: 
Monday, May 15, 2023

MCLEAN, Va., May 15, 2023 /PRNewswire/ -- Iridium Communications Inc. (NASDAQ: IRDM) today announced that Jacqueline Yeaney has been elected to the Iridium Board of Directors, effective May 4, 2023.

Key Points: 
  • MCLEAN, Va., May 15, 2023 /PRNewswire/ -- Iridium Communications Inc. (NASDAQ: IRDM) today announced that Jacqueline Yeaney has been elected to the Iridium Board of Directors, effective May 4, 2023.
  • As a director on the Iridium Board, Yeaney will contribute to the strategic direction of Iridium's business alongside her fellow Board members.
  • Recently retired, Yeaney has extensive experience in the high-tech software and analytics industry, as well as in management consulting.
  • She has served on the Board of Directors for other publicly traded companies, including Avaya Holdings Corp., and Promethean World PLC.

Century Therapeutics Announces Leadership Changes

Retrieved on: 
Wednesday, April 12, 2023

PHILADELPHIA, April 12, 2023 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology, today announced the appointment of Greg Russotti, Ph.D., as ad-interim Chief Executive Officer, effective April 11, 2023. Dr. Russotti, who has served as the Company’s Chief Technology Officer since January 2020, is succeeding Lalo Flores, Ph.D., who has stepped down as Chief Executive Officer and as a member of the Company’s Board of Directors to pursue other opportunities. In addition, effective April 11, 2023, Michael C. Diem, M.D., was promoted to the role of Chief Financial Officer, and Hy Levitsky, M.D., assumed his prior role as President of Research and Development.

Key Points: 
  • “Lalo has played a key role in advancing Century, a premier cell therapy company, to where it is today.
  • Prior to Celgene, he held various leadership roles at Merck Research Laboratories, developing vaccines and monoclonal antibodies for clinical and commercial manufacturing.
  • Prior to joining Century, he was Senior Vice President of Business and Corporate Development at Amicus Therapeutics, and prior to that, he held a similar role at Aevi Genomic Medicine.
  • He currently serves as a member of the Board of Directors of Replimune, Prokarium, and Carisma Therapeutics.

PointClickCare Announces Brian Drozdowicz as Senior Vice President and General Manager of Acute & Payer Markets

Retrieved on: 
Thursday, April 13, 2023

PointClickCare Technologies , a leading healthcare technology platform enabling meaningful collaboration and access to real‐time insights at every stage of the patient healthcare journey, today announced the appointment of Brian Drozdowicz as Senior Vice President and General Manager of Acute & Payer Markets.

Key Points: 
  • PointClickCare Technologies , a leading healthcare technology platform enabling meaningful collaboration and access to real‐time insights at every stage of the patient healthcare journey, today announced the appointment of Brian Drozdowicz as Senior Vice President and General Manager of Acute & Payer Markets.
  • “Brian is a well-respected leader who is wholeheartedly committed to our mission and purpose,” said Dave Wessinger , Chief Executive Officer and co-founder at PointClickCare.
  • “His alignment to our values and his track record of successfully growing, scaling and transforming businesses makes him a perfect fit to lead our acute and payer efforts.
  • PointClickCare completed its network expansion, expanding one of the largest real-time coordination nationwide networks in North America.

Splunk Appoints Toni Pavlovich as Chief Customer Officer

Retrieved on: 
Wednesday, April 12, 2023

Splunk Inc. (NASDAQ: SPLK), the cybersecurity and observability leader, today announced Toni Pavlovich has been appointed as Chief Customer Officer (CCO).

Key Points: 
  • Splunk Inc. (NASDAQ: SPLK), the cybersecurity and observability leader, today announced Toni Pavlovich has been appointed as Chief Customer Officer (CCO).
  • Reporting to Gary Steele, President and Chief Executive Officer of Splunk, Pavlovich is responsible for championing customer experience while fostering a customer-first mindset and culture across Splunk.
  • View the full release here: https://www.businesswire.com/news/home/20230412005387/en/
    Splunk Appoints Toni Pavlovich as Chief Customer Officer (Photo: Business Wire)
    With over 30 years of experience, Pavlovich joined Splunk in 2017 and most recently led its Global Professional Services organization where she built a high-performance team that supports Splunk’s growing customer base.
  • “As our Chief Customer Officer and a passionate Splunker, Toni is known for her purposeful approach and commitment to ensuring the best possible experience for our customers.

21 Finalists Compete in the 2023 Global Scaling Challenge (Virtually)… April 14th & 15th

Retrieved on: 
Wednesday, April 12, 2023

The University of New Mexico (UNM) has announced the finals of the 2023 UNM Anderson Global Scaling Challenge (UNM Anderson GSC) where 21 exceptional University student teams from around the world have qualified to compete for $30,000 in cash prizes.

Key Points: 
  • The University of New Mexico (UNM) has announced the finals of the 2023 UNM Anderson Global Scaling Challenge (UNM Anderson GSC) where 21 exceptional University student teams from around the world have qualified to compete for $30,000 in cash prizes.
  • The University of New Mexico President Dr. Garnett S. Stokes will provide the opening remarks on Friday April 14th.
  • Dean Dr. Julie Coonrod of UNM’s Anderson School of Management will provide opening remarks on Saturday April 15th.
  • Please visit https://gsc.mgt.unm.edu to learn about the conference, sponsorship opportunities and obtain a zoom link to view the challenge.

Virtual Technologies Group Names IT Veteran Dean Marsh as CEO

Retrieved on: 
Tuesday, April 4, 2023

MAUMEE, Ohio, April 4, 2023 /PRNewswire/ -- Virtual Technologies Group (VTG), a leading IT, security, and cloud services firm providing customized solutions with vertical focus in education, non-profit, manufacturing, and healthcare has announced today that it has named Dean J. Marsh as Chief Executive Officer.

Key Points: 
  • MAUMEE, Ohio, April 4, 2023 /PRNewswire/ -- Virtual Technologies Group (VTG), a leading IT, security, and cloud services firm providing customized solutions with vertical focus in education, non-profit, manufacturing, and healthcare has announced today that it has named Dean J. Marsh as Chief Executive Officer.
  • Mr. Marsh will be responsible for driving the next stage of growth for the company.
  • Mr. Marsh brings over 30 years of experience in driving extraordinary revenue growth in the information technology sector.
  • "The team could not be more thrilled to welcome Dean to our firm," said Tom Allen, President of VTG.

Dr. Mark "Merriwether" Vorderbruggen of Medicine Man Plant Co. Awarded the Title of Medicinal Plants Expert

Retrieved on: 
Friday, March 31, 2023

NEW YORK, March 31, 2023 /PRNewswire/ -- Dr. Mark "Merriwether" Vorderbruggen of Texas-based Medicine Man Plant Co., has won recognition from Plant-Based Health News (a digital publication) as an acclaimed medicinal plants expert.

Key Points: 
  • NEW YORK, March 31, 2023 /PRNewswire/ -- Dr. Mark "Merriwether" Vorderbruggen of Texas-based Medicine Man Plant Co., has won recognition from Plant-Based Health News (a digital publication) as an acclaimed medicinal plants expert.
  • His website, www.foragingtexas.com is one of the internet's top wild edible / medicinal plant sites.
  • [ See Full Release ]
    As the herbalist/scientist in charge of product formulations for Medicine Man Plant Co ., Dr. Vorderbruggen applies his training in medicinal chemistry and plant molecules to create unique formulations grounded in traditional medicine and based on time-tested and proven folk remedies.
  • Vorderbruggen says the better option is to turn to scientifically supported mixes of ancient plants and mushrooms to achieve natural healing.

DEKRA APPOINTS JOHN TESORO TO LEAD AMERICAS REGION

Retrieved on: 
Wednesday, March 29, 2023

today announced that John Tesoro has joined the company as Executive Vice President and President of DEKRA Americas, Inc., where he will lead the testing, inspection, and certification organization in North and South America.

Key Points: 
  • today announced that John Tesoro has joined the company as Executive Vice President and President of DEKRA Americas, Inc., where he will lead the testing, inspection, and certification organization in North and South America.
  • John Tesoro to lead testing, inspection, and certification organization DEKRA in North and South America.
  • "John brings a successful track-record of driving business growth and advancing solution portfolios through a customer-centric approach," said DEKRA CEO Stan Zurkiewicz.
  • "I have great respect for the people, leadership, and core purpose of DEKRA, and I am honored and grateful to lead the team in the Americas," said Tesoro.

Advent International Appoints Biopharma Executive James Mullen as Operating Partner

Retrieved on: 
Tuesday, March 28, 2023

Advent International (“Advent”), one of the largest and most experienced global private equity investors, today announced the appointment of seasoned biopharma executive James (“Jim”) Mullen as an Operating Partner.

Key Points: 
  • Advent International (“Advent”), one of the largest and most experienced global private equity investors, today announced the appointment of seasoned biopharma executive James (“Jim”) Mullen as an Operating Partner.
  • “Jim has been a renowned leader in the biopharma sector for over four decades,” said John Maldonado, Managing Partner at Advent.
  • Mullen currently serves as the Executive Chairman of Editas Medicine, a leading genome editing company, where he previously served as the company’s President and CEO.
  • Mullen served as the CEO and director of Patheon, a pharmaceutical and manufacturing organization serving the pharmaceutical and biotechnology sectors.

Integrum Worldwide Retains DAC Capital as Exclusive Buy-side Advisor

Retrieved on: 
Wednesday, March 15, 2023

LOS ANGELES, March 15, 2023 /PRNewswire/ -- Integrum Worldwide, the global marketing agency collective backed by Apollo Management and M2B Growth Enterprises, today announced that DAC Capital has been retained as Integrum's exclusive buy-side advisory firm. Led by David Abraham, DAC Capital will support Integrum, as well as its two agencies Storia and Chalk, as the collective continues making strategic acquisitions in various marketing service areas.

Key Points: 
  • LOS ANGELES, March 15, 2023 /PRNewswire/ -- Integrum Worldwide , the global marketing agency collective backed by Apollo Management and M2B Growth Enterprises, today announced that DAC Capital has been retained as Integrum's exclusive buy-side advisory firm.
  • Led by David Abraham, DAC Capital will support Integrum, as well as its two agencies Storia and Chalk , as the collective continues making strategic acquisitions in various marketing service areas.
  • Abraham, DAC Capital's principal, has completed transactions including acquisitions, asset sales, financings throughout the capital structure, restructurings and work-outs, and other corporate financial activities.
  • "I've worked with David and his firm DAC Capital in various capacities over the years and I'm excited to be able to bring him on-board to help us continue to scale at Integrum Worldwide," said Claude Zdanow, Integrum Worldwide's President.